Try our Advanced Search for more refined results

Expert Analysis

If High Court Reverses Teva, Litigation Costs May Increase

Law360, New York (October 15, 2014, 8:37 PM EDT) -- In recent years, the U.S. Supreme Court has shown an increasing willingness to review and, more often than not, reverse, patent law decisions from the Federal Circuit. As others have observed, the Supreme Court's growing interest in patent law seems to be motivated by policy concerns about the scope and costs of the patent system. Unfortunately, our analysis suggests that the policy arguments presented to the court in its latest patent law case, Teva Pharmaceuticals USA Inc. v. Sandoz Inc., which was argued Wednesday, are off-base....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!